Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 9 (NPM1P9)
- Target
- NPM1P9
- Molecular classification
- Pseudogene, Other
01
Overview
Nucleophosmin 1 pseudogene 9 (NPM1P9) is a genomic sequence in humans similar to the nucleophosmin (NPM1) gene but classified as a pseudogene. Unlike protein-coding genes, pseudogenes like NPM1P9 are generally non-functional, do not encode proteins, and are not transcribed or translated into products that perform biological roles. NPM1P9 is not associated with disease, is not a target for drug development, and has no established molecular classification beyond its designation as a pseudogene. The related functional gene, NPM1, participates in ribosome biogenesis, genomic stability, apoptosis, and has major disease relevance in hematological malignancies (specifically acute myeloid leukemia)[1][3][4][5], but these properties do not apply to NPM1P9.
- Other names
- NPM1 pseudogene 9Nucleophosmin pseudogene 9
02
Mechanism of action
None. Mechanisms of action do not apply, as NPM1P9 is not an active molecular target.
03
Biological functions
None known. As a pseudogene, NPM1P9 does not have established biological function or protein product.
04
Disease associations
None known. NPM1 (the functional gene) is implicated in various cancers, especially acute myeloid leukemia, but NPM1P9 itself does not have a recognized role in disease states[4][5].
05
Safety considerations
None known. There are no therapeutic concerns related to NPM1P9.
06
Interacting drugs
None. There are no drugs known to interact with NPM1P9.
07
Biomarkers
None known or used for patient selection or monitoring.
Beyond the preview
Go deeper on Nucleophosmin 1 pseudogene 9 (NPM1P9).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 9 (NPM1P9).